IRIS Accounts Production v24.3.2.46 09276465 Board of Directors 1.11.23 31.10.24 31.10.24 false true false false true false Ordinary 1.00000 Ordinary B 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh092764652023-10-31092764652024-10-31092764652023-11-012024-10-31092764652022-10-31092764652022-11-012023-10-31092764652023-10-3109276465ns15:EnglandWales2023-11-012024-10-3109276465ns14:PoundSterling2023-11-012024-10-3109276465ns10:Director12023-11-012024-10-3109276465ns10:PrivateLimitedCompanyLtd2023-11-012024-10-3109276465ns10:SmallEntities2023-11-012024-10-3109276465ns10:AuditExempt-NoAccountantsReport2023-11-012024-10-3109276465ns10:SmallCompaniesRegimeForDirectorsReport2023-11-012024-10-3109276465ns10:SmallCompaniesRegimeForAccounts2023-11-012024-10-3109276465ns10:FullAccounts2023-11-012024-10-3109276465ns10:OrdinaryShareClass12023-11-012024-10-3109276465ns10:OrdinaryShareClass22023-11-012024-10-3109276465ns10:Director22023-11-012024-10-3109276465ns10:RegisteredOffice2023-11-012024-10-3109276465ns5:CurrentFinancialInstruments2024-10-3109276465ns5:CurrentFinancialInstruments2023-10-3109276465ns5:ShareCapital2024-10-3109276465ns5:ShareCapital2023-10-3109276465ns5:RetainedEarningsAccumulatedLosses2024-10-3109276465ns5:RetainedEarningsAccumulatedLosses2023-10-3109276465ns5:FurnitureFittings2023-11-012024-10-3109276465ns5:ComputerEquipment2023-11-012024-10-3109276465ns5:FurnitureFittings2023-10-3109276465ns5:ComputerEquipment2023-10-3109276465ns5:FurnitureFittings2024-10-3109276465ns5:ComputerEquipment2024-10-3109276465ns5:FurnitureFittings2023-10-3109276465ns5:ComputerEquipment2023-10-3109276465ns5:WithinOneYearns5:CurrentFinancialInstruments2024-10-3109276465ns5:WithinOneYearns5:CurrentFinancialInstruments2023-10-3109276465ns5:DeferredTaxation2023-10-3109276465ns5:DeferredTaxation2023-11-012024-10-3109276465ns5:DeferredTaxation2024-10-3109276465ns10:OrdinaryShareClass12024-10-3109276465ns10:OrdinaryShareClass22024-10-31092764651ns10:Director12023-10-31092764651ns10:Director12022-10-31092764651ns10:Director12023-11-012024-10-31092764651ns10:Director12022-11-012023-10-31092764651ns10:Director12024-10-31092764651ns10:Director12023-10-31
REGISTERED NUMBER: 09276465 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31ST OCTOBER 2024

FOR

QUALITY PROFESSIONAL PHARMA SERVICES LTD

QUALITY PROFESSIONAL PHARMA SERVICES LTD (REGISTERED NUMBER: 09276465)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST OCTOBER 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


QUALITY PROFESSIONAL PHARMA SERVICES LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 31ST OCTOBER 2024







DIRECTORS: S Simpson
Mrs J Simpson





REGISTERED OFFICE: 36-40 Doncaster Road
Barnsley
South Yorkshire
S70 1TL





REGISTERED NUMBER: 09276465 (England and Wales)





ACCOUNTANTS: Seaman Herbert & Co
36 - 40 Doncaster Road
Barnsley
South Yorkshire
S70 1TL

QUALITY PROFESSIONAL PHARMA SERVICES LTD (REGISTERED NUMBER: 09276465)

BALANCE SHEET
31ST OCTOBER 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 5,692 6,824

CURRENT ASSETS
Debtors 5 82,513 38,332
Investments 6 166,437 96,592
Cash at bank 134,210 182,221
383,160 317,145
CREDITORS
Amounts falling due within one year 7 97,942 63,984
NET CURRENT ASSETS 285,218 253,161
TOTAL ASSETS LESS CURRENT
LIABILITIES

290,910

259,985

PROVISIONS FOR LIABILITIES 8 1,423 1,501
NET ASSETS 289,487 258,484

CAPITAL AND RESERVES
Called up share capital 9 100 100
Retained earnings 289,387 258,384
SHAREHOLDERS' FUNDS 289,487 258,484

QUALITY PROFESSIONAL PHARMA SERVICES LTD (REGISTERED NUMBER: 09276465)

BALANCE SHEET - continued
31ST OCTOBER 2024


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st October 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st October 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit & Loss Account and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 18th January 2025 and were signed on its behalf by:





S Simpson - Director


QUALITY PROFESSIONAL PHARMA SERVICES LTD (REGISTERED NUMBER: 09276465)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST OCTOBER 2024

1. STATUTORY INFORMATION

Quality Professional Pharma Services Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 10% on reducing balance
Computer equipment - 33% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit & Loss Account and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

QUALITY PROFESSIONAL PHARMA SERVICES LTD (REGISTERED NUMBER: 09276465)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31ST OCTOBER 2024

4. TANGIBLE FIXED ASSETS
Fixtures
and Computer
fittings equipment Totals
£    £    £   
COST
At 1st November 2023 6,346 6,630 12,976
Additions - 700 700
At 31st October 2024 6,346 7,330 13,676
DEPRECIATION
At 1st November 2023 2,071 4,081 6,152
Charge for year 426 1,406 1,832
At 31st October 2024 2,497 5,487 7,984
NET BOOK VALUE
At 31st October 2024 3,849 1,843 5,692
At 31st October 2023 4,275 2,549 6,824

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 63,572 37,928
Directors' current accounts 18,516 -
Prepayments 425 404
82,513 38,332

6. CURRENT ASSET INVESTMENTS
2024 2023
£    £   
Listed investments 166,437 96,592

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Tax 64,019 37,437
VAT 32,273 23,465
Directors' current accounts - 1,502
Accrued expenses 1,650 1,580
97,942 63,984

QUALITY PROFESSIONAL PHARMA SERVICES LTD (REGISTERED NUMBER: 09276465)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31ST OCTOBER 2024

8. PROVISIONS FOR LIABILITIES
2024 2023
£    £   
Deferred tax 1,423 1,501

Deferred
tax
£   
Balance at 1st November 2023 1,501
Provided during year (78 )
Balance at 31st October 2024 1,423

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
60 Ordinary £1 60 60
40 Ordinary B £1 40 40
100 100

10. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31st October 2024 and 31st October 2023:

2024 2023
£    £   
S Simpson
Balance outstanding at start of year (1,502 ) (1,232 )
Amounts advanced 20,018 -
Amounts repaid - (270 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 18,516 (1,502 )

11. ULTIMATE CONTROLLING PARTY

The directors hold 100% of the issued share capital.